Here are relevant reports on : patient-adherence-market

• Patient Experience Technology Market by Offering, Function [Appointment (Online Booking), Registration (Intake), Virtual Care (Telehealth, RPM), Communication, Feedback], End User (Providers, Payers, Pharma & Biotech), Region - Global Forecast to 2030

  The global patient experience technology market, valued at US$0.59 billion in 2024, stood at US$0.66 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. This robust growth is due to the rising adoption of telemedicine and AI-driven engagement tools, coupled with government-backed digital health initiatives that promote patient-centered care and accessibility.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Medical Device Connectivity Market by Product & Services, Technology, Application (Vital Signs & Patient Monitors, Ventilators, Anesthesia Machines, Infusion Pumps, Imaging Systems, Respiratory devices), End User, and Region - Global Forecast to 2028

  The global medical device connectivity market, valued at US$2.1 billion in 2022, stood at US$2.6 billion in 2023 and is projected to advance at a resilient CAGR of 21.5% from 2023 to 2028, culminating in a forecasted valuation of US$7.4 billion by the end of the period. This growth is driven by factors such as healthcare provider consolidations, telehealth expansion, and increasing home healthcare preferences.

  • Published: December 2023
  • Price: $ 4950
  • TOC Available:

• Biometrics As a Service in Healthcare Market by Component, Modality (Unimodal, Multimodal), Solution Type (Fingerprint, Iris, Vein Recognition), Application (Patient Identification, Medical Record Security), Region - Global Forecast to 2028

  The global biometrics as a service in healthcare market, valued at US$0.3 billion in 2022, stood at US$0.4 billion in 2023 and is projected to advance at a resilient CAGR of 20.7% from 2023 to 2028, culminating in a forecasted valuation of US$1.1 billion by the end of the period. Significant strides in biometric technologies, including innovations like palm vein scanning, iris recognition, and facial recognition, have ushered in a new era of heightened accuracy and user-friendliness.

  • Published: April 2024
  • Price: $ 4950
  • TOC Available:

• Remote Patient Monitoring (RPM) Market by Offering [Software, Device (Wearable, Implants, Handheld)], Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User (Hospital, ASC, Pharma & Biotech) - Global Forecast to 2031

  The global remote patient monitoring market is projected to reach USD 66.33 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

  The global assisted reproductive technology market, valued at US$4.02 billion in 2024, stood at US$4.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$6.02 billion by the end of the period. The Asia Pacific region is expected to grow at the highest CAGR of 7.9% during the forecast period owing to the increasing infertility rates, rising awareness of fertility treatments, and improving healthcare infrastructure.

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Patient Derived Xenografts/PDX Models Market by Type (Mouse, Rat), Service (Model Creation, Characterization), Implantation Method (Subcutaneous), Tumor Type (Respiratory, GI, Gynecological), Application (Preclinical, Biomarker) - Global Forecast to 2030

  The global patient derived xenografts/PDX models market, valued at US$0.32 billion in 2024, stood at US$0.37 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation of US$0.66 billion by the end of the period. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response.

  • Published: November 2025
  • Price: $ 4950
  • TOC Available:

• US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030

  The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024

  The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.

  • Published: December 2019
  • Price: $ 4950
  • TOC Available:

• Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User - Forecast to 2030

  Europe Remote Patient Monitoring (RPM) market, valued at US$6.16 billion in 2024, stood at US$6.87 billion in 2025 and is projected to advance at a resilient CAGR of 10.3% from 2024 to 2030, culminating in a forecasted valuation of US$11.22 billion by the end of the period.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• NLP in Healthcare & Life Sciences Market by NLP Technique (OCR, NER, Sentiment Analysis), Application (Genomics & Precision Medicine, Patient Care & Engagement, Clinical Operations & Decision Support, Biomedical Research) - Global Forecast to 2030

  The NLP in healthcare & life sciences market is expanding rapidly, with a projected market size anticipated to rise from about USD 5.18 billion in 2025 to USD 16.01 billion by 2030, featuring a CAGR of 25.3%. The major players in the NLP in healthcare & life sciences market include Microsoft (US), Google (US), IQVIA (US), Oracle (US), IBM (US), Lexalytics (US), Averbis (Germany), Emtelligent (Canada), Gnani.ai (India), and Deep 6 AI (US).

  • Published: May 2025
  • Price: $ 7150
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50